ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$288.18
Tradestie Score
54
Market Cap
$60.38B
P/E Ratio
72.0
Revenue Growth
1.0%
Analyst Upside
+51.4%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$618.03
|
$63.59B | 14.9 | 67 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$853.40
|
$46.96B | 41.1 | 67 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$276.13
|
$36.81B | 61.4 | 57 | Compare |
|
INSM
Insmed, Inc.
|
$102.15
|
$31.13B | - | 61 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.62
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$25.94
|
$19.56B | 19.5 | 62 | Compare |
|
INCY
Incyte Genomics Inc
|
$104.40
|
$16.93B | 14.6 | 60 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$55.35
|
$15.70B | 27.9 | 60 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.25
|
$15.22B | - | 50 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$161.44
|
$13.59B | 24.9 | 60 | Compare |
More ALNY Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry